HI
RXRX icon

Hoey Investments’s Recursion Pharmaceuticals RXRX Stock Holding History

Hoey Investments’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.67K Hold
1,000
– – ﹤0.01% 317
2026
Q1 		$3.07K Hold
1,000
– – ﹤0.01% 313
2025
Q4 		$4.09K Sell
1,000
-500
-33% -$2.48K ﹤0.01% 301
2025
Q3 		$7.32K Buy
1,500
+500
+50% +$2.63K ﹤0.01% 267
2025
Q2 		$5.06K Hold
1,000
– – ﹤0.01% 277
2025
Q1 		$5.29K Buy
+1,000
New +$7.29K ﹤0.01% 243

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Hoey Investments's RXRX Position: Q2 2026 in Review

Hoey Investments held its Recursion Pharmaceuticals (RXRX) position steady in Q2 2026 at 1,000 shares worth $3.67K. The position accounts for ﹤0.01% of the portfolio, ranked #317.

Hoey Investments first reported a position in RXRX in Q1 2025 and has held it in 6 quarters since. The position peaked at $7.32K in Q3 2025. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Hoey Investments held 1,000 shares of Recursion Pharmaceuticals worth $3.67K as of Q2 2026.
  • Hoey Investments left its Recursion Pharmaceuticals share count unchanged in Q2 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of Hoey Investments's portfolio in Q2 2026, its #317 holding.
  • Hoey Investments first reported a position in Recursion Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Hoey Investments's Recursion Pharmaceuticals position peaked at $7.32K in Q3 2025.
  • 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Hoey Investments's 13F filing for Q2 2026, filed 27 Jul 2026.